Zacks.com on MSN4h
MGTX Stock Up on Upbeat Efficacy Data From Parkinson's Disease StudyMeiraGTx Holdings’ MGTX clinical bridging study of its gene therapy candidate, AAV-GAD, for treating Parkinson’s disease (PD) ...
Tagtik on MSN8d
Parkinson's disease: finally a promising treatmentA sparkling shot... almost magical, to treat Parkinson's. American researchers have conducted several clinical trials, rather ...
ScienceAlert on MSN7d
Parkinson's Discovery Suggests We Already Have an FDA-Approved TreatmentParkinson's symptoms mainly result from the death or impairment of dopamine-producing neurons in the brain's substantia nigra ...
A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A ...
"We, 100% can tell everyone who comes in the room who is diagnosed with PD, if you exercise, your disease will go slower than ...
Shares in MeiraGTx rose after the company said it received positive data in a clinical bridging study of AAV-GAD for the treatment of Parkinson's disease. Shares were up nearly 14% in premarket ...
WLKY Louisville on MSN1d
Norton Healthcare first in Kentucky to offer non-invasive treatment for tremorsNorton Healthcare is now able to offer patients suffering from Essential Tremors and Parkinson's Disease some relief. The ...
12d
Parkinson's disease is a chronic and progressive disorder that affects the central nervous system, primarily the brain, and ...
MeiraGTx Holdings (MGTX) stock gains in premarket trading after positive trial results for the company's AAV-GAD gene therapy ...
Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ...
Parkinson’s is a neurodegenerative disease with no known cure. Parkinson’s Dynamics in Huntsville provides patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback